Tag: apple

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016^® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.

Mit einer zum Patent angemeldeten Formel und einer internationalen Expansion positioniert sich BioAro als Vorreiter im milliardenschweren Langlebigkeits- und Wellnesssektor

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apple Inc. (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, both dates inclusive (the “Class Period”), of the important August 19, 2025 lead plaintiff deadline.

The smart TV sticks market will grow by USD 962.7 million from 2024-2029, at a 9% CAGR. A comprehensive report analyzes market size, trends, growth drivers, and challenges. Segments include Type, Distribution Channel, Connectivity, OS, and Geography. Key players include Amazon, Apple, and Google.

While competitors push high-THC options, Area 52’s Delta 8 Gummies lead with a balanced, clear-headed experience—now joined by UFO MAX and UFO in the top 3

TORONTO, Canada, July 04, 2025 (GLOBE NEWSWIRE) -- Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at June 30, 2025 was $70.37 resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 2.3% and 14.3%, respectively. These compare with the 10.2% and 26.4% returns of the benchmark S&P/TSX Composite Index on a total return basis for the same periods.